Giulia Musso
Overview
Explore the profile of Giulia Musso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ceolin C, Scala A, Rocca M, Scagnet B, Marton M, Simonato C, et al.
J Endocrinol Invest
. 2025 Jan;
PMID: 39746882
Purpose: Previous studies show that transgender and gender-diverse (TGD) individuals, especially those assigned male at birth (AMAB), often have low bone mineral density (BMD) before beginning gender-affirming hormone therapy (GAHT)....
2.
Aita A, Galozzi P, Zemin F, Principi G, Contran N, Musso G, et al.
PLoS One
. 2024 Nov;
19(11):e0314234.
PMID: 39585877
Objective: Salivary alpha-amylase (sAA) has been recently proposed as biomarker of stress responsiveness within the sympathetic nervous system, preferable to cortisol, since limitations related to cortisol measurement (e.g. diurnal and...
3.
Musso G, Gabelli C, Cagnin A, Cosma C, Cecchin D, Zorzi G, et al.
Clin Chem Lab Med
. 2024 Nov;
63(4):e113-e116.
PMID: 39530774
No abstract available.
4.
Musso G, Gabelli C, Puthenparampil M, Cosma C, Cagnin A, Gallo P, et al.
Clin Chim Acta
. 2024 Oct;
565:120014.
PMID: 39442787
Background: Advances in analytical methods have recently paved the way to Alzheimer's disease (AD) biomarkers testing in blood along with the more established CSF testing. To ensure a forthcoming application...
5.
Musso G, Blasi L, Mion M, Fortuna A, Sabbatini D, Zaninotto M, et al.
J Neurol Sci
. 2023 Dec;
456:122816.
PMID: 38071852
Serum biomarkers that might detect clinical progression are currently lacking for Spinal and bulbar muscular atrophy (SBMA), thus limiting the effectiveness of possible future pharmacological trials. Elevation of cardiac troponin...
6.
Carrer T, Bonato G, Sandre M, Emmi A, Campagnolo M, Musso G, et al.
Neurol Sci
. 2023 Sep;
45(1):309-313.
PMID: 37752324
Background: Multiple system atrophy (MSA) is considered a primarily sporadic neurodegenerative disease, but the role of genetic is poorly understood. Case: We present a female patient of Moroccan origin who...
7.
Padoan A, Musso G, Contran N, Basso D
Curr Issues Mol Biol
. 2023 Jul;
45(7):5534-5557.
PMID: 37504266
In this review, the role of innate and adaptive immunity in the pathogenesis of inflammatory bowel diseases (IBD) is reported. In IBD, an altered innate immunity is often found, with...
8.
Musso G, Zoccarato M, Gallo N, Padoan A, Cosma C, Zuliani L, et al.
Clin Chem Lab Med
. 2023 Apr;
61(10):1802-1807.
PMID: 37114858
Objectives: Antibodies against glutamic acid decarboxylase isoform 65 (GAD-Ab) have been found in different severe neurological conditions associated with altered synthesis of γ-aminobutyric acid (GABA). Serum GAD-Ab can be found...
9.
Pre-analytical variability of the Lumipulse immunoassay for plasma biomarkers of Alzheimer's disease
Musso G, Cosma C, Zaninotto M, Gabelli C, Basso D, Plebani M
Clin Chem Lab Med
. 2022 Nov;
61(3):e53-e56.
PMID: 36423341
No abstract available.
10.
Zuin J, Fogar P, Musso G, Padoan A, Piva E, Pelloso M, et al.
Lab Med
. 2022 Jun;
53(6):609-613.
PMID: 35716073
Objective: To identify the potential prognostic value of lymphocyte subsets in COVID-19 patients, where lymphopenia is a common finding. Methods: In 353 COVID-19 inpatients and 40 controls T cell subsets...